StockData
Arrowhead Pharmaceuticals, Inc. logo

Arrowhead Pharmaceuticals, Inc. (ARWR) stock

ARWRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-K on Nov 12, 2026Score 5/3035% above fair value
$43.11+0.12 (+0.28%)

Close on Nov 18, 2026Market cap $6.09BP/E –Yield –

Arrowhead Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Arrowhead Pharmaceuticals's price to sales ratio was 10.4× on Nov 11, 2026, against 8.6× a year earlier. Over the last 5 years it ranged from 4.0× to 150.7×, with a median of 14.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202610.4×−0.5
2025Dec 31, 202510.9×−110.7
2024Oct 31, 2024121.6×+107.9
2023Dec 29, 202313.6×−4.0
2022Dec 30, 202217.7×−32.3
2021Dec 31, 202150.0×−39.3
2020Dec 31, 202089.3×+53.4
2019Dec 31, 201935.9×−32.2
2018Dec 31, 201868.1×+59.3
2017Dec 29, 20178.8×−428.7
2013Jul 31, 2013437.5×+239.6
2012Dec 31, 2012197.8×+75.6
2011Dec 30, 2011122.3×–

More Arrowhead Pharmaceuticals figures

See a number that looks wrong?